back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-26 18:14 Tx date 2024-04-23 |
$LSL
LSL Pharma Group Inc. |
Dellafera, Frank J.
4 - Director of Issuer
Holder: Alfera Pharmaceuticals, LLC (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$875,000
+1,250,000 vol $0.70 each |
1,271,428 | |
| Filed 2024-04-26 18:12 Tx date 2024-04-23 |
$LSL
LSL Pharma Group Inc. |
Dellafera, Frank J.
4 - Director of Issuer
Holder: Alfera Pharmaceuticals, LLC (Indirect Ownership)
|
Common Shares catégorie A
16 - Acquisition or disposition under a prospectus exemption
|
$500,000
+1,250,000 vol $0.40 each |
1,292,857 | |
| Filed 2023-03-03 23:48 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Dellafera, Frank J.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2023-03-03 23:47 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Dellafera, Frank J.
4 - Director of Issuer
Holder: Alfera Pharmaceuticals, LLC (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
21,428 | ||
| Filed 2023-03-03 23:47 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Dellafera, Frank J.
4 - Director of Issuer
Holder: Alfera Pharmaceuticals, LLC (Indirect Ownership)
|
Common Shares catégorie A
00 - Opening Balance-Initial SEDI Report
|
42,857 |